000			nam a22 7a 4500
999			_c10437 _d10437
005			20211216114732.0
008			191205b xxu||||| |||| 00| 0 eng d
020			_a9781439848005 _qCRC website
020			_a9780367269265 _qIndian edition
040			_cAIKTC-KRRC
041			_aENG
082			_2DDC23 _a617.7061 _bTHA/CHA
100			_94175 _aThassu, Deepak _eEditor
245			_aOcular drug delivery systems _b: Barriers and application of nanoparticulate systems
260			_aBoca Raton _bCRC Press _c2013
300			_axv, 447p. _bHard Bound _c23.5*16 cm
520			_aDrug discovery for ocular diseases has taken great strides in the last two decades. From cornea to choroid, new drugs have been formulated to address a great variety of ocular diseases. Yet without good drug delivery systems, these drugs are less effective than they might be or could even cause serious side effects. Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems presents research on the development of currently marketed devices and recent trends in the topical delivery of drugs to the posterior of the eye. With contributions from leading pharmaceutical researchers and industry experts, eye researchers, surgeons, pharmacologists from academia, the National Eye Institute, and leading ophthalmic companies such as Pfizer, Allergan, and Novartis, the book presents the state of the art in the use of nanoparticles in ocular drug delivery systems and also sets the stage for future developments. This volume provides both a current evaluation and a future roadmap for developments in ocular drug delivery. The subjects range from biological needs to material challenges and finally to clinical applications for improving drug delivery for conditions where treatments already exist. It also explores areas where effective drugs may be currently available but yet need a safe, efficient, and efficacious delivery vehicle. _bTable of Contents Basic Considerations Nanoparticle-Based Therapeutics: An Overview Deepak Thassu, Kris Holt, and Gerald J. Chader Eye Anatomy, Physiology and Ocular Barriers: Basic Considerations for Drug Delivery Gerald J. Chader and Deepak Thassu Animal Models to Evaluate Ocular Nanoparticular Drug Delivery Systems Vinson M. Wang, Jingsheng Tuo, and Chi-Chao Chan Computer Modeling for Ocular Drug Delivery Paul J. Missel Challenges in the Development of Nanotechnology-Based Ophthalmic Systems Banu S. Zolnik, Sheriza Baksh, and Nakissa Sadrieh Ocular Barriers Blood–Retinal Barrier: The Fundamentals Rosa Fernandes, Andreia Gonçalves, and José Cunha-Vaz Barriers to Transscleral Drug Delivery to the Retina Alexandra Almazan, Susan S. Lee, Aron D. Ross, and Michael R. Robinson Ocular Compartment Drug Delivery Drug Delivery to the Vitreous Humor Francine Behar-Cohen Transscleral and Suprachoroidal Drug Delivery Damian E. Berezovsky and Henry F. Edelhauser Protein Drug Delivery to Retina and Choroid Hongwen M. Rivers and Patrick M. Hughes Transscleral Drug Delivery to the Posterior Segment of the Eye Bernard F. Godley, Cheryl L. Rowe-Rendleman, Ed Kraft, and Gabriella Kulp Drug Delivery to the Suprachoroidal Space Sung Won Cho and Timothy W. Olsen Use of Nanoparticles in the Treatment of Age-Related Macular Degeneration, Glaucoma, and Other Degenerative Retinal Diseases Marco A. Zarbin, Carlo Montemagno, James F. Leary, and Robert Ritch Drug Delivery Systems Drug Molecule Characteristics, Drug Delivery Strategies and Their Impact on Ophthalmic Drug Delivery to Anterior versus Posterior Segments Kay D. Rittenhouse Surface Modulation of Nanoparticles Deepak Thassu and Kris Holt Nanoparticles for the Treatment of Retinal Diseases Amin Famili and Uday B. Kompella Gene-Based Medicine for Ocular Diseases Shannon M. Conley and Muna I. Naash Stealth-Type Polymeric Nanoparticles with Encapsulated Betamethasone Phosphate for Treatment of Intraocular Inflammation Tsutomu Sakai, Tsutomu Ishihara, and Megumu Higaki Technology and Materials Development Nanotechnology-Guided Imaging of Retinal Vascular Disease Joshua R. Trantum and Ashwath Jayagopal Photoresponsive Polymers for Ocular Drug Delivery Laura A. Wells and Heather Sheardown Nanosuspensions in Ocular Drug Delivery Systems Himanshu Bhattacharjee and Sonia Bedi
650		0	_97371 _aPHARMACOTHERAPEUTICS
653			_aTHERAPEUTICS
700			_911019 _aChader, Gerald J. _eEditor
942			_2ddc _cBK